AI assistant
Biocon Ltd. — Board/Management Information 2020
Jan 23, 2020
61176_rns_2020-01-23_20fe761f-cfeb-45d7-828b-1b269fb1ee12.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [146 x 29] intentionally omitted <==
| Biocon Limited | Biocon Limited | ||||
|---|---|---|---|---|---|
| 20thKMHosur | Road | ||||
| Electronics City | |||||
| January23,2020 | Bangalore 560 | 100, India | |||
| T9180 2808 2808 | |||||
| F9180 2852 3423 | |||||
| To, | To, | UN: | , I~~:u<>r~~ | (003417 | |
| TheManager | TheManager | www.biocon.com | |||
| BSELimited | National Stock ExchangeofIndia Limited | ||||
| DepartmentofCorporate Services | Corporate Communication Department | ||||
| Phiroze Jeejeebhoy Towers, | ExchangePlaza,Bandra Kurla Complex | ||||
| DalalStree~,Mumbai-400 001 | Mumbai-400050 | ||||
| Scrip Code - 532523 | ScripSymbol - Biocon |
==> picture [79 x 29] intentionally omitted <==
==> picture [81 x 81] intentionally omitted <==
==> picture [135 x 47] intentionally omitted <==
ANNEXURE A
Details under Regulation 30 of the SEBI Listing Regulations read along with SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015
| ANNEXURRegulation 30 of the SEBI Listing Regulations read along with SEBI circularCIR/CFD/CMD/4/2015 dated September 9 2015 | ||||||||
| Details under | ANNEXURegulation 30 of the SEBI Listing Regulations read along with SEBI circularCIR/CFD/CMD/4/2015 dated September 9 2015 | |||||||
| , | ||||||||
| S. No. | ||||||||
| Pa | rticulars | Ms. Kiran Mazumdar Shaw | ||||||
| 1. | Reason for change viz. appointment,resignation,removal,deathorotherwise; | ason for chane viz | ointment | Completionoftenureasthe | Chane in desination f | |||
| ManagingDirectorandRe-appointmentasExecutiveChairperson of the Company. | ||||||||
| 2. | Date of appointment/ cessation (asapplicable) & term of appointment; | For a period of 5 years commencingfrom April 1, 2020. | Managing Director effective fromApril 1, 2020 andall other termsand conditions will remain same asapproved by the Board at itsmeetingheld on October 23,2019. | |||||
| 3. | Brief profile(in case of appointment); | Attached asAnnexure B | Attached asAnnexure C | |||||
| 4. | Disclosure of relationships betweendirectors (in case of appointment of adirector). | Mr. John Mccallum Marshall Shaw,Vice-Chairperson and Non-ExecutiveDirector – SpouseMr. Ravi Mazumdar, Non-ExecutiveDirector - Brother | Not applicable |
ANNEXURE B
==> picture [135 x 47] intentionally omitted <==
BRIEF PROFILE – MS. KIRAN MAZUMDAR SHAW
==> picture [149 x 127] intentionally omitted <==
Ms. Kiran Mazumdar-Shaw is a pioneering biotech entrepreneur, a healthcare visionary, and a passionate philanthropist. Her vision is to enable universal access to high quality medical products, particularly to address the global chronic disease burden. She is a pioneer of India’s biotech industry and founder of Biocon, an innovation-led global biotechnology enterprise.
Her visionary journey has earned her several coveted titles and awards, both national and international, including India’s top
civilian awards, Padma Shri and Padma Bhushan, as well as, the highest French distinction, Knight of the Legion of Honour and Australia’s Highest Civilian Honour the Order of Australia. A well-regarded global influencer, she has been named among TIME magazine’s ‘100 Most Influential People in the World’.
Ms Shaw also serves on the board of Infosys, Narayana Health and IIT Bombay, besides being the former Chairperson of IIM Bengaluru.
Ms Mazumdar-Shaw holds a bachelor’s degree in science (Zoology Hons.) from Bangalore University and has earned a master’s degree in malting and brewing from Ballarat College, Melbourne University. She has been awarded with several honorary degrees from Ballarat (2004), University of Abertay (2007), University of Glasgow (2008), Heriot-Watt University (2008), National University of Ireland (2012) and Trinity College, Dublin (2012) for her pre-eminent contributions in the field of biotechnology.
ANNEXURE C
==> picture [135 x 47] intentionally omitted <==
BRIEF PROFILE - MR. SIDDHARTH MITTAL
==> picture [138 x 136] intentionally omitted <==
Mr. Siddharth Mittal, CEO and Joint Managing Director, joined Biocon in May 2013 and since August 2014, he has served as the President - Finance and Chief Financial Officer of Biocon Limited till November 2019.
He has over 20 years of global and diversified experience in the field of strategic finance and accounting, mergers and acquisitions, taxation and general management.
Mr. Mittal started his career with the audit division of S.R. Batliboi & Co. (Indian arm of Ernst & Young) based out of Bengaluru. He then worked with the US subsidiary of Xchanging Plc, a London-based, FTSE-listed company specialising in business processing, technology and procurement services. There, he held senior leadership positions in finance, including Finance Director of BPO and IT US divisions.
Prior to joining Biocon, he was Vice President, Finance and Corporate Controller with Symphony Teleca, a leading US-based multinational IT company.
Mr. Mittal has a Bachelor of Commerce (B. Com) degree from the Symbiosis College of Arts and Commerce, Pune. He is a Chartered Accountant from the Institute of Chartered Accountants of India, New Delhi and a Certified Public Accountant from Colorado, USA.